Philippe Maerten
Impact in
-
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Immune Response and Inflammation
Papers in
-
- Immune Cell Function and Interaction 5
- T-cell and B-cell Immunology 4
- Galectins and Cancer Biology 1
- Immunotherapy and Immune Responses 1
- Genetics 4
- Inflammatory Bowel Disease 4
- Co-authors
- Jan Ceuppens (9 shared papers)Paul Rutgeerts (7 shared papers)Zhanju Liu (4 shared papers)Karel Geboes (4 shared papers)Chong Shen (6 shared papers)Gert Van Assche (4 shared papers)Karel Geboes (3 shared papers)Peter W. Hellings (1 shared paper)
- Journals
- Gastroenterology (2 papers)BioDrugs (1 paper)Clinical Cancer Research (1 paper)Inflammatory Bowel Diseases (1 paper)Clinical Immunology (1 paper)
- Partner nations
- BelgiumSwitzerlandUnited States
In The Last Decade
Philippe Maerten
12 papers receiving 228 citations
Peers
Comparison fields: 5 of 44
- Immunology 124
- Immunology and Allergy 9
- Genetics 42
- Oncology 37
- Neurology 10
Countries citing papers authored by Philippe Maerten
This map shows the geographic impact of Philippe Maerten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Maerten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Maerten more than expected).
Fields of papers citing papers by Philippe Maerten
This network shows the impact of papers produced by Philippe Maerten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Maerten. The network helps show where Philippe Maerten may publish in the future.
Co-authors
The 25 scholars most cited alongside Philippe Maerten, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 81 | |
| 2 | 2005 | 53 | |
| 3 | 2016 | 32 | |
| 4 | 2010 | 21 | |
| 5 | 2004 | 15 | |
| 6 | 2003 | 11 | |
| 7 | In vitro analysis of interferon gamma (IFN-gamma) and interleukin-12 (IL-12) production and their effects in ileal Crohn's disease. | 2003 | 8 |
| 8 | 2007 | 3 | |
| 9 | 2003 | 3 | |
| 10 | A fully human anti-TNF mAb adalimumab (D2E7) induces caspase-dependent apoptosis of human peripheral blood monocyte and T cells | 2004 | 2 |
| 11 | In vitro analysis of IGN-gamma and IL-12 production and their effects in ileal Crohn’s disease | 2003 | 1 |
| 12 | 2010 | 1 |
About Philippe Maerten
Philippe Maerten is a scholar working on Immunology, Genetics, Epidemiology, Oncology and Surgery, having authored 12 papers that have together received 231 indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (5 papers), T-cell and B-cell Immunology (4 papers), Inflammatory Bowel Disease (4 papers), Microscopic Colitis (3 papers), Cytokine Signaling Pathways and Interactions (2 papers), Potassium and Related Disorders (1 paper), Galectins and Cancer Biology (1 paper) and Immunotherapy and Immune Responses (1 paper). The work is most often cited by research in Immunology (124 citations), Immunology and Allergy (9 citations), Genetics (42 citations), Oncology (37 citations) and Neurology (10 citations). Philippe Maerten has collaborated with scholars based in Belgium, Switzerland and United States. Frequent co-authors include Jan Ceuppens, Paul Rutgeerts, Zhanju Liu, Karel Geboes, Chong Shen, Gert Van Assche, Karel Geboes, Peter W. Hellings, Peter van Kooten and Louis Boon. Their work appears in journals such as Gastroenterology, BioDrugs, Clinical Cancer Research, Inflammatory Bowel Diseases and Clinical Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.